Sydney Morning Herald
Australia
Danny Rose, Medical Writer
August 24, 2010 – 6:04PM
AAP
Young women in Australia are shunning the uncomfortable, but potentially life-saving, Pap test.
The First International HPV Vaccine Information Clearinghouse
Sydney Morning Herald
Australia
Danny Rose, Medical Writer
August 24, 2010 – 6:04PM
AAP
Young women in Australia are shunning the uncomfortable, but potentially life-saving, Pap test.
6 Minutes
by Michael Woodhead
August 20, 2010
Immunisation experts say there is no immediate need to consider switching from the current quadrivalent HPV vaccine (Gardasil) to a ‘stronger’ bivalent vaccine (Cervarix).
Medicine Journal Feeds
AIDS. 2010 Aug 11;
Authors: Kuhn L, Wang C, Tsai WY, Wright TC, Denny L
BACKGROUND:: Cervical cancer prevention should be provided as part of primary healthcare services for HIV-infected women but conventional screening programs are difficult to implement in low-resource settings.
Obstetrics & Gynecology:
July 2010 – Volume 116 – Issue 1 – pp 76-84
doi: 10.1097/AOG.0b013e3181e3e719
Original Research
Castle, Philip E. PhD, MPH; Fetterman, Barbara SCT (ASCP); Thomas Cox, J.; Shaber, Ruth MD; Poitras, Nancy ACS, PMP; Lorey, Thomas MD; Kinney, Walter MD
Abstract
BACKGROUND: To estimate the relationship of human papillomavirus (HPV) detection and abnormal cytology with histologic diagnoses of cervical precancer and cancer.
Medicine Journal Feeds
Gynecol Oncol. 2010 Aug 14;
Authors: Vijayaraghavan A, Efrusy MB, Goodman KA, Santas CC, Huh WK
OBJECTIVE: Testing for human papillomavirus (HPV) 16 and 18 genotypes, which are known to cause approximately 65-70% of invasive cervical cancer cases, may allow clinicians to identify women at highest risk for underlying cervical intraepithelial neoplasia missed by Pap cytology.